According to analysts citing IQVIA data, the obesity pill was prescribed 3,707 times in week two, showing strong momentum over the 1,390 prescriptions logged in its debut week
It is entirely normal to wonder if medication is truly necessary when you have no symptoms, but medical experts strongly advise that lifelong L-carnitine supplementation is still required [3] [1] [4]
Retatrutide is the latest entry in this evolutionary chain, often referred to in literature as a "triagonist." It adds Glucagon receptor (GCGR) agonism to the existing GLP-1 and GIP targets
The journey to optimal health and longevity is a marathon, not a sprint
And one recent study saw significantly higher IGF-1 levels in women with ovarian cancer compared to healthy controls (22)
Assessed the association of genetically proxied GLP-1RAs with T2D and obesity